Showing results (31-40 of 117) with videos related to
Sort By:
Pageof 12
Journal of Medicinal Chemistry|April 29, 2005
1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitorsMariangela Biava, Giulio Cesare Porretta, Andrea Cappelli, et al.Journal of Medicinal Chemistry|May 13, 2005
Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory propertiesAndrea Cappelli, Andrea Gallelli, Monica Manini, et al.Clinical and Experimental Rheumatology|December 18, 2020
Naturalistic 6-month antidepressants follow-up in patients with fibromyalgia: impact on somatic and mood spectrum symptomsClaudia Carmassi, Antonio Ciapparelli, Andrea Cappelli, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 5, 2013
Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytesClaudia Sticozzi, Giuseppe Belmonte, Franco Cervellati, et al.CNS Spectrums|April 19, 2021
Investigating the relationship between orthorexia nervosa and autistic traits in a university populationBarbara Carpita, Ivan Mirko Cremone, Giulia Amatori, et al.Chemical Communications (Cambridge, England)|June 24, 2014
Dendrimeric tetravalent ligands for the serotonin-gated ion channelMarco Paolino, Laura Mennuni, Germano Giuliani, et al.Current Topics in Medicinal Chemistry|February 20, 2010
The interactions of the 5-HT3 receptor with quipazine-like arylpiperazine ligands: the journey track at the end of the first decade of the third millenniumAndrea Cappelli, Stefania Butini, Antonella Brizzi, et al.The Journal of Physical Chemistry Letters|April 18, 2019
Bile Acid Binding Protein Functionalization Leads to a Fully Synthetic Rhodopsin MimicKatiuscia Pagano, Marco Paolino, Stefania Fusi, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 23, 2025
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylationValerio Ciccone, Claudia Cecchin, Maria Frosini, et al.Journal of the American Chemical Society|June 21, 2016
Design, Synthesis, and Dynamics of a Green Fluorescent Protein Fluorophore Mimic with an Ultrafast Switching FunctionMarco Paolino, Moussa Gueye, Elisa Pieri, et al.Pageof 12